Related Experiment Video
Updated: Jul 19, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Immunoabsorbent nanoparticles based on a tobamovirus displaying protein A
Stefan Werner1, Sylvestre Marillonnet, Gerd Hause
1Icon Genetics and University of Halle, Biocenter, Weinbergweg 22, D-06120 Halle (Saale), Germany.
Researchers successfully displayed a large protein fragment on tobamovirus nanoparticles, creating an inexpensive immunoadsorbent for antibody purification. This novel self-assembling matrix offers high capacity and purity for monoclonal antibody (mAb) production.
Area of Science:
- * Virology
- * Protein Engineering
- * Nanobiotechnology
Background:
- * Previous efforts to display peptides longer than 20 amino acids (aa) on tobamovirus surfaces were unsuccessful.
- * Tobamoviruses, like tobacco mosaic virus, are plant viruses amenable to surface display engineering.
Purpose of the Study:
- * To engineer tobamovirus nanoparticles for displaying functional protein fragments.
- * To develop a cost-effective immunoadsorbent for monoclonal antibody (mAb) purification.
Main Methods:
- * A 133 aa functional fragment of protein A was genetically fused to the tobamovirus coat protein via a 15 aa linker.
- * The resulting engineered tobamovirus nanoparticles were expressed in plants and purified.
- * The nanoparticles were utilized as an immunoadsorbent for mAb purification.
Main Results:
- * A functional 133 aa protein A fragment was successfully displayed on tobamovirus nanoparticles.
- * A simple purification protocol yielded mAbs with 50% recovery and >90% purity.
- * Dense packing (>2,100 copies/particle) resulted in high binding capacity (2 g mAb/g).
- * High expression levels (>3 g adsorbent/kg biomass) indicate cost-effectiveness.
Conclusions:
- * Engineered tobamovirus nanoparticles serve as an effective platform for displaying large functional protein fragments.
- * This self-assembling matrix provides an inexpensive, high-capacity immunoadsorbent for industrial mAb purification.
- * The system demonstrates potential for single-use, large-scale antibody purification applications.
More Related Videos
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
05:15Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay
Published on: February 10, 2022